Net shares · 365d
-445.4K
0 buy · 445.4K sell
Net value · 365d
-$1.6M
$0 in · $1.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
4
0 buy · 445.4K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
CLOV Sell·S
CEO, Counterpart Health · 10b5-1
$879.5K
220.4K sh · $3.99
Own -14%
-
CLOV Other·F
CEO, Counterpart Health
$47.9K
23.5K sh · $2.04
Own -2%
-
CLOV Grant·A
CEO, Counterpart Health
$0
267.8K sh
Own +29%
-
CLOV Other·F
CEO, Counterpart Health
$198.4K
100.2K sh · $1.98
Own -10%
-
CLOV Other·F
CEO, Counterpart Health
$72.7K
25.9K sh · $2.81
Own -2%
-
CLOV Other·F
CEO, Counterpart Health
$265.7K
98.4K sh · $2.70
Own -9%
-
CLOV Other·F
CEO, Counterpart Health
$439.1K
124.4K sh · $3.53 avg · 2 lots
Own -10%
-
CLOV Other·F
CEO, Counterpart Health
$258.1K
92.2K sh · $2.80
Own -7%
-
CLOV Other·F
CEO, Counterpart Health
$301.1K
98.4K sh · $3.06
Own -6%
-
CLOV Other·F
CEO, Counterpart Health
$80.7K
27.9K sh · $2.89
Own -2%
-
CLOV Sell·S
CEO, Counterpart Health · 10b5-1
$693.0K
209.8K sh · $3.30 avg · 2 lots
Own -13%
-
CLOV Sell·S
CEO, Counterpart Health · 10b5-1
$49.6K
15.2K sh · $3.26
Own -1%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | CLOV | Sell S | 220.4K | $879.5K |
| Apr 15, 2026 | CLOV | Other F | 23.5K | $47.9K |
| Apr 1, 2026 | CLOV | Grant A | 267.8K | $0 |
| Mar 14, 2026 | CLOV | Other F | 100.2K | $198.4K |
| Jan 15, 2026 | CLOV | Other F | 25.9K | $72.7K |
| Dec 14, 2025 | CLOV | Other F | 98.4K | $265.7K |
| Oct 31, 2025 | CLOV | Other F | 124.4K2 lots | $439.1K |
| Oct 15, 2025 | CLOV | Other F | 92.2K | $258.1K |
| Sep 14, 2025 | CLOV | Other F | 98.4K | $301.1K |
| Jul 31, 2025 | CLOV | Other F | 27.9K | $80.7K |
| Jul 23, 2025 | CLOV | Sell S | 209.8K2 lots | $693.0K |
| Jul 8, 2025 | CLOV | Sell S | 15.2K | $49.6K |
Buy Sell Non-market (grant · exercise · gift)
About Wai Conrad
This profile aggregates every SEC Form 4 insider transaction reported by Wai Conrad across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.